The mammalian target of rapamycin (mTOR) is the master regulator of autophagy [34,35] and an hyper-activation of mTOR—which negatively regulates autophagy induction—along with the reduction of the autophagic flux was reported in AD [36,37,38,39]. This evidence concerns the gene MTOR and Alzheimer disease.